Flow Cytometric Immune Profiling in Infliximab-Associated Tuberculosis.

about

Flow Cytometric Immune Profiling in Infliximab-Associated Tuberculosis.

Item

http://www.wikidata.org/entity/Q40054600

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Flow Cytometric Immune Profiling in Infliximab-Associated Tuberculosis.

@en

type

Item

label

Flow Cytometric Immune Profiling in Infliximab-Associated Tuberculosis.

@en

prefLabel

Flow Cytometric Immune Profiling in Infliximab-Associated Tuberculosis.

@en

P1476

Flow Cytometric Immune Profiling in Infliximab-Associated Tuberculosis.

@en

P2093

Courtney L Erskine

http://www.w3.org/2001/XMLSchema#string

Guiherme P Ramos

http://www.w3.org/2001/XMLSchema#string

Humberto C Sasieta

http://www.w3.org/2001/XMLSchema#string

Kelly Pennington

http://www.w3.org/2001/XMLSchema#string

Patricio Escalante

http://www.w3.org/2001/XMLSchema#string

Tobias Peikert

http://www.w3.org/2001/XMLSchema#string

Virginia P Van Keulen

http://www.w3.org/2001/XMLSchema#string

P2860

Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent

Whole-blood flow-cytometric analysis of antigen-specific CD4 T-cell cytokine profiles distinguishes active tuberculosis from non-active states

Immunology of tuberculosis

TNF regulates chemokine induction essential for cell recruitment, granuloma formation, and clearance of mycobacterial infection.

Tumor necrosis factor alpha stimulates killing of Mycobacterium tuberculosis by human neutrophils.

Combinatorial Immunoprofiling in Latent Tuberculosis Infection. Toward Better Risk Stratification

Biomarkers on patient T cells diagnose active tuberculosis and monitor treatment response.

Gamma interferon release assays for detection of Mycobacterium tuberculosis infection.

Multi-functional flow cytometry analysis of CD4+ T cells as an immune biomarker for latent tuberculosis status in patients treated with tumour necrosis factor (TNF) antagonists.

A novel assay detecting recall response to Mycobacterium tuberculosis: Comparison with existing assays.

P304

1179547617724776

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

case report

P356

10.1177/1179547617724776

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-08-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28890660

http://www.w3.org/2001/XMLSchema#string

P932

5574471

http://www.w3.org/2001/XMLSchema#string